Technological progress is the primary engine behind the Antitumor Antibiotics Market. From 2025 to 2035, the industry is expected to evolve from traditional delivery methods to highly sophisticated, targeted systems. This shift is essential for treating patients with complex medical profiles, as it allows for smaller doses with higher therapeutic impacts, directly addressing the need for better...